Literature DB >> 3965163

Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamster.

G Galliani, A Assandri, D Barone, M Grandi, G Mistrello, G C Lancini.   

Abstract

L-Alanosine [L-2-amino-3(N-hydroxy-N-nitrosamino)propionic acid], a tumor-inhibiting agent, induces pregnancy arrest after single or multiple SC or PO administration to rats and hamsters. Its contragestational effects are dose- and route-dependent, with no important differences in species-sensitivity or administration schedules. L-Alanosine is maximally effective shortly (3-4 days) after implantation. Both placenta and fetus appear to be target tissues. Consistent with previous in vitro findings, adenine but not aspartic acid counteracts the contragestational action of L-alanosine. The 'contragestational test', i.e., the effect on conceptus growth, appears to be an interesting approach for learning more about the antiproliferative activity of an antineoplastic agent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965163     DOI: 10.1007/bf00552730

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  18 in total

1.  Decrease in fertility, fecundity, and egg size after feeding alanosine to Phormia regina.

Authors:  R G Kratsas
Journal:  J Econ Entomol       Date:  1975-10       Impact factor: 2.381

Review 2.  Cytotoxic drugs in pregnancy. Review of reported cases.

Authors:  H O Nicholson
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-03

3.  Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey.

Authors:  G van Wagenen; R C DeConti; R E Handschumacher; M E Wade
Journal:  Am J Obstet Gynecol       Date:  1970-09-15       Impact factor: 8.661

4.  Mode of action of alanosine.

Authors:  G R Gale; G B Schmidt
Journal:  Biochem Pharmacol       Date:  1968-03       Impact factor: 5.858

5.  Effects of alanosine on purine and pyrimidine synthesis.

Authors:  G R Gale; W E Ostrander; L M Atkins
Journal:  Biochem Pharmacol       Date:  1968-09       Impact factor: 5.858

6.  Metabolites of alanosine, an antitumor antibiotic.

Authors:  H N Jayaram; A K Tyagi; S Anandaraj; J A Montgomery; J A Kelley; J Kelley; R H Adamson; D A Cooney
Journal:  Biochem Pharmacol       Date:  1979-12-15       Impact factor: 5.858

7.  Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.

Authors:  J C Graff; P G Plagemann
Journal:  Cancer Res       Date:  1976-04       Impact factor: 12.701

8.  Isolation and structure of alanosine, a new antibiotic.

Authors:  C Coronelli; C R Pasqualucci; G Tamoni; G G Gallo
Journal:  Farmaco Sci       Date:  1966-04

9.  Contragestational effects of DL-alpha-difluoro-methylornithine, an irreversible inhibitor of ornithine decarboxylase, in the hamster.

Authors:  G Galliani; G Colombo; F Luzzani
Journal:  Contraception       Date:  1983-08       Impact factor: 3.375

10.  A new non-hormonal pregnancy-terminating agent.

Authors:  G Galliani; A Assandri; L Gallico; F Luzzani; C Oldani; A Omodei-Salè; A Soffientini; G Lancini
Journal:  Contraception       Date:  1981-02       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.